Nonalcoholic And Alcoholic Fatty Liver Disease

The first half of 2023 has already seen landmark FDA decisions in the gastroenterology space, including multiple first-in-class therapies along with two costly rejections that highlight persistent gaps in the GI drug armory.

The Obesity Medicine Association’s conference is always the must-attend event for health care providers to learn the latest advancements in obesity medicine and connect with colleagues at the forefront of treating patients with obesity.

The Liver Meeting 2022 delivered the latest research and developments on a variety of topics, including acute hepatitis in children, treatment for hepatitis-related cirrhosis and liver disease mortality during the COVID-19 pandemic.

WASHINGTON — Age-standardized mortality rates for alcohol-associated liver disease and nonalcoholic fatty liver disease increased the most among the young and non-Hispanic whites, Blacks and Native Americans during the COVID-19 pandemic.

Researchers have identified higher rates of young-onset colorectal cancer mortality among patients in the Midwest and Great Lakes regions.

A recent study found that fecal microbiota-based screening may help detect early-stage pancreatic cancer.

The American Diabetes Association recently published its annual Standards of Medical Care in Diabetes report. It provides new and updated practice guidelines, including recommendations for screening and treatment based on comorbidities.

People with a parent, sibling or child with diabetes have increased risk for developing nonalcoholic fatty liver disease, or NAFLD, regardless of their own glucose status, according to study findings.

A presenter at the North American Society for Pediatric Gastroenterology, Hepatology & Nutrition Annual Meeting discussed the effect of nutrition among pediatric patients with nonalcoholic fatty liver disease.

A low carbohydrate intervention targeting type 2 diabetes reversal and prediabetes regression may be an effective treatment method for nonalcoholic fatty liver disease, according to a speaker at The Liver Meeting Digital Experience.